Record Information |
---|
Version | 2.0 |
---|
Created at | 2021-06-19 21:59:27 UTC |
---|
Updated at | 2021-06-29 23:58:51 UTC |
---|
NP-MRD ID | NP0030709 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | salsolinol |
---|
Provided By | JEOL Database |
---|
Description | Salsolinol belongs to the class of organic compounds known as tetrahydroisoquinolines. These are tetrahydrogenated isoquinoline derivatives. Salsolinol has been detected, but not quantified in, several different foods, such as bananas (Musa acuminata), cocoa beans (Theobroma cacao), french plantains (Musa X paradisiaca), and opium poppies (Papaver somniferum). This could make salsolinol a potential biomarker for the consumption of these foods. Salsolinol is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. salsolinol is found in Aconitum carmichaeli , Aristolochia arcuata and Tinospora crispa . salsolinol was first documented in 2018 (PMID: 30251672). Based on a literature review a significant number of articles have been published on Salsolinol (PMID: 33871963) (PMID: 33355691) (PMID: 33277238) (PMID: 33080132) (PMID: 32881676) (PMID: 31240312). |
---|
Structure | [H]OC1=C(O[H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])N([H])[C@@]2([H])C([H])([H])[H] InChI=1S/C10H13NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-6,11-13H,2-3H2,1H3/t6-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-Salsolinol | HMDB | 1,2,3,4-Tetrahydro-1-methyl-(S)-6,7-isoquinolinediol | HMDB | Salsolinol, (S)-isomer | HMDB | Salsolinol hydrobromide | HMDB | Salsolinol, (+-)-isomer | HMDB | 1-Methyl-6,7-dihydroxytetrahydroisoquinoline | HMDB | Salsolinol | KEGG |
|
---|
Chemical Formula | C10H13NO2 |
---|
Average Mass | 179.2157 Da |
---|
Monoisotopic Mass | 179.09463 Da |
---|
IUPAC Name | (1S)-1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol |
---|
Traditional Name | salsolinol |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]OC1=C(O[H])C([H])=C2C(=C1[H])C([H])([H])C([H])([H])N([H])[C@@]2([H])C([H])([H])[H] |
---|
InChI Identifier | InChI=1S/C10H13NO2/c1-6-8-5-10(13)9(12)4-7(8)2-3-11-6/h4-6,11-13H,2-3H2,1H3/t6-/m0/s1 |
---|
InChI Key | IBRKLUSXDYATLG-LURJTMIESA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tetrahydroisoquinolines. These are tetrahydrogenated isoquinoline derivatives. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Tetrahydroisoquinolines |
---|
Sub Class | Not Available |
---|
Direct Parent | Tetrahydroisoquinolines |
---|
Alternative Parents | |
---|
Substituents | - Tetrahydroisoquinoline
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Benzenoid
- Azacycle
- Secondary amine
- Secondary aliphatic amine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Kim S, Jang EY, Song SH, Kim JS, Ryu IS, Jeong CH, Lee S: Brain Microdialysis Coupled to LC-MS/MS Revealed That CVT-10216, a Selective Inhibitor of Aldehyde Dehydrogenase 2, Alters the Neurochemical and Behavioral Effects of Methamphetamine. ACS Chem Neurosci. 2021 May 5;12(9):1552-1562. doi: 10.1021/acschemneuro.1c00039. Epub 2021 Apr 19. [PubMed:33871963 ]
- Capetian P, Roessner V, Korte C, Walitza S, Riederer F, Taurines R, Gerlach M, Moser A: Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome: reflection of dopaminergic hyperactivity? J Neural Transm (Vienna). 2021 Jan;128(1):115-120. doi: 10.1007/s00702-020-02289-6. Epub 2020 Dec 23. [PubMed:33355691 ]
- Britto-Junior J, Fernandes Jacintho F, Campos R, Pinheiro DHA, Figueiredo Murari GM, de Souza VB, Schenka AA, Monica FZ, Moreno RA, Antunes E, De Nucci G: The basal release of endothelium-derived catecholamines regulates the contractions of Chelonoidis carbonaria aorta caused by electrical-field stimulation. Biol Open. 2021 Jan 20;10(1). pii: bio.057042. doi: 10.1242/bio.057042. [PubMed:33277238 ]
- Carmo-Goncalves P, Romao L, Follmer C: In Vitro Protective Action of Monomeric and Fibrillar alpha-Synuclein on Neuronal Cells Exposed to the Dopaminergic Toxins Salsolinol and DOPAL. ACS Chem Neurosci. 2020 Nov 4;11(21):3541-3548. doi: 10.1021/acschemneuro.0c00527. Epub 2020 Oct 20. [PubMed:33080132 ]
- Voon SM, Ng KY, Chye SM, Ling APK, Voon KGL, Yap YJ, Koh RY: The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson's Disease. CNS Neurol Disord Drug Targets. 2020;19(10):725-740. doi: 10.2174/1871527319666200902134129. [PubMed:32881676 ]
- Vazquez-Manjarrez N, Weinert CH, Ulaszewska MM, Mack CI, Micheau P, Petera M, Durand S, Pujos-Guillot E, Egert B, Mattivi F, Bub A, Dragsted LO, Kulling SE, Manach C: Discovery and Validation of Banana Intake Biomarkers Using Untargeted Metabolomics in Human Intervention and Cross-sectional Studies. J Nutr. 2019 Oct 1;149(10):1701-1713. doi: 10.1093/jn/nxz125. [PubMed:31240312 ]
- Berrios-Carcamo P, Rivera-Meza M, Herrera-Marschitz M, Zapata-Torres G: Molecular modeling of salsolinol, a full Gi protein agonist of the mu-opioid receptor, within the receptor binding site. Chem Biol Drug Des. 2019 Aug;94(2):1467-1477. doi: 10.1111/cbdd.13523. Epub 2019 May 3. [PubMed:30920734 ]
- do Carmo-Goncalves P, Coelho-Cerqueira E, Cortines JR, de Souza TLF, Romao L, Follmer C: In vitro neurotoxicity of salsolinol is attenuated by the presynaptic protein alpha-synuclein. Biochim Biophys Acta Gen Subj. 2018 Dec;1862(12):2835-2845. doi: 10.1016/j.bbagen.2018.08.022. Epub 2018 Sep 3. [PubMed:30251672 ]
- Chen X, Zheng X, Ali S, Guo M, Zhong R, Chen Z, Zhang Y, Qing H, Deng Y: Isolation and Sequencing of Salsolinol Synthase, an Enzyme Catalyzing Salsolinol Biosynthesis. ACS Chem Neurosci. 2018 Jun 20;9(6):1388-1398. doi: 10.1021/acschemneuro.8b00023. Epub 2018 Apr 12. [PubMed:29602279 ]
- Zheng X, Chen X, Guo M, Ali S, Huang Y, Sun F, Liu K, Chen Z, Deng Y, Zhong R: Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model. Neurosci Lett. 2018 Apr 23;673:39-43. doi: 10.1016/j.neulet.2018.02.024. Epub 2018 Feb 15. [PubMed:29454627 ]
- Francisco, M. C., et al. (2003). Francisco, M. C., et al., Phytochemistry 62, 1265 (2003) . Phytochem..
|
---|